Pharma Mar, S.A.
PHMMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $175 | $158 | $196 | $230 |
| % Growth | 10.6% | -19.5% | -14.6% | – |
| Cost of Goods Sold | $8 | $10 | $14 | $16 |
| Gross Profit | $167 | $149 | $183 | $213 |
| % Margin | 95.3% | 93.9% | 93.1% | 92.8% |
| R&D Expenses | $104 | $99 | $83 | $72 |
| G&A Expenses | -$3 | $18 | $19 | $17 |
| SG&A Expenses | -$3 | $42 | $43 | $40 |
| Sales & Mktg Exp. | $0 | $24 | $24 | $22 |
| Other Operating Expenses | $59 | $11 | $12 | $9 |
| Operating Expenses | $160 | $152 | $138 | $121 |
| Operating Income | $6 | -$4 | $44 | $92 |
| % Margin | 3.7% | -2.4% | 22.4% | 40.2% |
| Other Income/Exp. Net | $6 | $0 | -$0 | -$6 |
| Pre-Tax Income | $12 | -$4 | $44 | $95 |
| Tax Expense | -$14 | -$5 | -$6 | $2 |
| Net Income | $26 | $1 | $49 | $93 |
| % Margin | 14.9% | 0.7% | 25.1% | 40.4% |
| EPS | 1.49 | 0.064 | 2.73 | 5.14 |
| % Growth | 2,246.5% | -97.7% | -46.9% | – |
| EPS Diluted | 1.49 | 0.064 | 2.73 | 5.13 |
| Weighted Avg Shares Out | 18 | 18 | 18 | 18 |
| Weighted Avg Shares Out Dil | 18 | 18 | 18 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $4 | $1 | $0 |
| Interest Expense | $2 | $2 | $2 | $3 |
| Depreciation & Amortization | $7 | $6 | $6 | $6 |
| EBITDA | $21 | $5 | $52 | $104 |
| % Margin | 12.1% | 2.9% | 26.5% | 45.3% |